Technology
Health
Pharmaceutical

KalVista Pharmaceuticals

$29.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.27 (4.50%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell KALV and other stocks, options, ETFs, and crypto commission-free!

About

KalVista Pharmaceuticals, Inc. Common Stock, also called KalVista Pharmaceuticals, is a pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors. Read More It offers small molecule plasma kallikrein for the treatment of hereditary angioedema; diabetic macular edema; and other plasma kallikrein-associated diseases. The company was founded by Crockett, T. Andrew, Edward P. Feener, and Lloyd P. Aiello and is headquartered in Cambridge, MA.

Employees
33
Headquarters
Cambridge, Massachusetts
Founded
—
Market Cap
486.37M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
67.77K
High Today
$29.47
Low Today
$27.35
Open Price
$27.91
Volume
50.22K
52 Week High
$34.92
52 Week Low
$7.73

Collections

Technology
Health
Pharmaceutical
2015 IPO
US
North America

News

BusinessWireFeb 25

KalVista Pharmaceuticals Presents Data at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting 2019

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced data from a poster presentation given Saturday, February 23, at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting 2019 in San Francisco, CA. “We are pleased to provide additional data on KVD900, showcasing a potentially ideal profile...

810

Earnings

-$0.50
-$0.38
-$0.25
-$0.13
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.45 per share
Actual
-$0.23 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.